Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Assoc Physicians India ; 71(7): 11-12, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37449692

ABSTRACT

INTRODUCTION: Post-coronavirus 2019 (COVID-19) complications are now well-recognized and may involve multiple organs. Post-COVID-19 pulmonary fibrosis is one of the serious long-term consequences of COVID-19 infection, and the risk factors for its development largely remain unidentified. AIMS AND OBJECTIVES: The study aimed to evaluate the clinical and radiological profile of post COVID-19 patients with diagnosed diabetes mellitus (DM). MATERIALS AND METHODS: All the patients attending the post-COVID-19 respiratory care center over a period of 1 year who were diagnosed with cases of DM were evaluated for residual clinical symptoms and radiological changes and glycosylated hemoglobin (HbA1c) levels were measured from their blood samples. RESULTS: A total of 50 patients were enrolled in this observational cross-sectional study. Most patients were males in the age group of 45-60 years. Approximately 74% of patients had uncontrolled DM. Patients with uncontrolled DM had a higher probability of having a severe disease with an odds ratio (OR) of 7.30 (0.85, 62.42, and confidence interval (CI) 95%) and were more likely to have fibrotic abnormalities on computed tomography (CT) chest with OR of 3.38 (0.87, 16.86, and CI 95%). CONCLUSION: Uncontrolled diabetes predisposes to the development of post-COVID-19 fibrosis, so physicians should be more vigilant while managing these patients.


Subject(s)
COVID-19 , Diabetes Mellitus , Male , Humans , Middle Aged , Female , COVID-19/complications , Diabetes Mellitus/epidemiology , Risk Factors , SARS-CoV-2 , Fibrosis
3.
Monaldi Arch Chest Dis ; 92(4)2022 Jan 27.
Article in English | MEDLINE | ID: mdl-35086327

ABSTRACT

Pulmonary tuberculosis (PTB) is an infectious disease caused by Mycobacterium tuberculosis (MTB) and is associated with significant mortality and morbidity. There has been a number of advances in the diagnosis of PTB but there is a need for simple blood based diagnostic test. A follow up of the patients on treatment remains challenging. This study was planned to evaluate the role of IP-10 in the follow up of PTB patients. A total of 60 subjects were enrolled in the study, 40 patients with confirmed diagnosis of PTB and 20 healthy controls. The value of interferon (IFN)γ inducible protein 10 (IP10) was measured in all the subjects at the start of the treatment and at a follow up of two months. Mean age of the study subjects was 40.96 years. Mean duration of symptoms at presentation was 1 month and 17 days. The induration on Tuberculin skin test (TST) was between 10-20mm in most (62.5%) of the study subjects. Majority (45%) showed moderately advanced disease on chest x-ray. There was no association of IP-10 with TST diameter and gene x-pert. Similarly, no significant difference in IP-10 levels was found in relation to sputum grading and x-ray score at diagnosis and after 2 months of treatment. IP-10 has very limited role in diagnosis of active TB in especially in high TB burden countries. The role of IP-10 in follow up of PTB patients could not be ascertained by our study. However, more studies are needed in this pretext with larger sample size and extended duration of follow up.


Subject(s)
Chemokine CXCL10 , Tuberculosis, Pulmonary , Adult , Follow-Up Studies , Humans , Interferons , Tuberculin Test , Tuberculosis, Pulmonary/diagnosis
4.
Monaldi Arch Chest Dis ; 91(1)2021 Jan 25.
Article in English | MEDLINE | ID: mdl-33501821

ABSTRACT

Dear Editor, The Corona virus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in the Wuhan province of china in December 2019. COVID-19 spread to the world in a short time and was declared as public health emergency of international concern by World Health Organization...


Subject(s)
COVID-19 , Diabetes Mellitus, Type 2 , Glycated Hemoglobin/analysis , Lung , Oxygen Inhalation Therapy/methods , Aged , COVID-19/complications , COVID-19/diagnosis , COVID-19/mortality , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/drug therapy , Fatal Outcome , Fibrosis/diagnosis , Fibrosis/etiology , Fibrosis/therapy , Glycemic Control/standards , Home Care Services , Humans , Lung/diagnostic imaging , Lung/pathology , Male , Risk Factors , SARS-CoV-2/isolation & purification , Tomography, X-Ray Computed/methods , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...